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Abstract
Background: STARS (STriated muscle Activator of Rho Signaling) is a sarcomeric protein expressed early in cardiac
development that acts as an acute stress sensor for pathological remodeling. However the role of STARS in cardiac
development and function is incompletely understood. Here, we investigated the role of STARS in heart development and
function in the zebrafish model and in vitro.
Methodology and Principal Findings: Expression of zebrafish STARS (zSTARS) first occurs in the somites by the 16 somite
stage [17 hours post fertilization (hpf)]. zSTARS is expressed in both chambers of the heart by 48 hpf, and also in the
developing brain, jaw structures and pectoral fins. Morpholino-induced knockdown of zSTARS alters atrial and ventricular
dimensions and decreases ventricular fractional shortening (measured by high-speed video microscopy), with pericardial
edema and decreased or absent circulation [abnormal cardiac phenotypes in 126/164 (77%) of morpholino-injected
embryos vs. 0/152 (0%) of control morpholino embryos]. Co-injection of zsrf (serum response factor) mRNA rescues the
cardiac phenotype of zSTARS knockdown, resulting in improved fractional shortening and ventricular end-diastolic
dimensions. Ectopic over-expression of STARS in vitro activates the STARS proximal promoter, which contains a conserved
SRF site. Chromatin immunoprecipitation demonstrates that SRF binds to this site in vivo and the SRF inhibitor CCG-1423
completely blocks STARS proximal reporter activity in H9c2 cells.
Conclusions/Significance: This study demonstrates for the first time that STARS deficiency severely disrupts cardiac
development and function in vivo and revealed a novel STARS-SRF feed-forward autoregulatory loop that could play an
essential role in STARS regulation and cardiac function.
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Introduction
Pathological cardiac remodeling due to sustained mechanical
stress, tissue injury and neurohormonal stimulus can lead to
hypertrophic growth, cardiomyopathy and heart failure. In order
to decipher the complexity of the multiple gene networks that
converge to initiate and coordinate such response, essential
upstream integral factors need to be identified and characterized.
STARS (STriated muscle Activator of Rho Signaling [also known
as MS1 (Myocyte Stress 1) and ABRA (Actin-Binding Rho
Activating-protein)], is an evolutionarily-conserved sarcomeric
actin binding protein that is acutely (and transiently) up-regulated
in response to pressure overload left ventricular hypertrophy with
a peak expression well before any detectable increase in left
ventricular (LV) mass [1], [2]. This suggests a possible role for
STARS in the initial signaling of cardiac remodeling such as the
hypertrophic response. Sustained over-expression of STARS in
the mouse heart have no effect on LV mass but resulted in an
increased sensitivity to hemodynamic stress leading to cardiac
hypertrophy and heart failure [3].
STARS expression parallels the development and regression of
skeletal muscle hypertrophy in humans [4]. Moreover, STARS
can stimulate serum response factor (SRF)-dependent transcription
in cultured cells by inducing the nuclear accumulation of the SRF
co-factors, myocardin-related transcription factors (MRTFs)
through a mechanism dependent on RhoA (ras homolog gene
family, member A) and actin polymerization [2], [5]. Forced over-
expression of STARS in vitro results in an increase in cell size,
induces expression of several MRTF/SRF target genes and
provides protection against apoptosis [6], providing further
evidence of its role in striated muscle pathophysiology.
STARS is expressed during embryonic cardiac development [1],
[2] and has been implicated as a key factor involved in myogenic
differentiation [7]. STARS could play a more widespread role in
PLoS ONE | www.plosone.org 1 July 2012 | Volume 7 | Issue 7 | e40966muscle pathophysiology such as fluid shear stress induced blood
vessel formation (arteriogenesis) [8], insulin resistance and fat
metabolism in skeletal muscle [9], [10]. To gain a better
understanding on the function and mechanism of STARS in
cardiac biology in vivo, we investigated the orthologue in zebrafish
and report that knockdown of STARS in zebrafish results in severe
contractile dysfunction that can be rescued by SRF. We also
provide evidence indicating that SRF can regulate STARS
transcription establishing a newly discovered autoregulatory
feed-forward loop for STARS-SRF signaling.
Results
Expression of zSTARS in the Zebrafish
The zebrafish STARS orthologue (zSTARS) contains a high
degree of homology to other STARS orthologues, particularly in
the actin-binding regions critical for signaling from actin to SRF-
mediated gene transcription (Figure S1, Text S1). Whole mount in
situ hybridization was performed in order to investigate the
developmental expression pattern of zSTARS. zSTARS expression
was detected in both the atrium and ventricle of the zebrafish
heart beginning at 48 hpf (Figure 1A–B). zSTARS transcript was
also detected in somites by the 16 somite stage (17 hpf) (Figure 1C–
E). Other notable embryonic sites of expression include the
developing brain (Figure 1D, E), jaw structures, and pectoral fins
(data not shown).
Knockdown of zSTARS in Zebrafish Leads to Structural
and Functional Cardiac Abnormalities
To assess the in vivo role of zSTARS during cardiac de-
velopment, we performed morpholino-induced knockdown of
zSTARS during zebrafish embryonic development. Injection of
a morpholino directed against the translation initiation site of
zSTARS causes a striking cardiovascular phenotype by 48–56 hpf
(126 out of 164 embryos, 77%). Morphologically, the heart tube is
incompletely looped, causing the atrium and ventricle to retain an
immature linear form (Figure 2A and B, Figure S2A and S2B).
The atrium is dilated, and overall contractility of both chambers
appears impaired (Movie S1, Movie S2). These cardiac abnor-
malities lead to significant pericardial edema, with congestion and
pooling of blood in the sinus venosus. The most significantly
affected embryos show complete absence of circulation despite
a beating heart. zSTARS morphants also exhibited abnormal
somite formation and curvature of the longitudinal axis, suggesting
an important developmental role for zSTARS in the non-cardiac
sites of expression (Figure 2C–E). In contrast, injection of a control
morpholino with five mismatches to the zSTARS sequence does
not cause obvious developmental abnormalities (0 out of 152
embryos; x
2=194, p,0.001) or obstruction of the outflow tract
(Figure S2C).
Over-expression of SRF Rescues the Cardiac Phenotype
Induced by zSTARS Knockdown
We quantified cardiac function and dimensions in zSTARS
morphants using high-speed video microscopy [11]. In addition to
the abnormal morphology of heart development, zSTARS
knockdown results in a smaller ventricle. Specifically, ventricular
end diastolic size is decreased compared to controls. At end systole,
the morphant ventricle is unable to contract to the same degree as
control ventricles resulting in a larger ventricular end diastolic size
(Figure 3A, Figure S3, Movie S1, Movie S2). Together, these
changes result in impaired cardiac performance shown by
a significant decrease in ventricular fractional shortening com-
pared to control (Figure 3B). Injection of zsrf mRNA suppresses
the cardiac phenotype induced by zSTARS knockdown: fractional
shortening (p,0.05) and ventricular systolic and diastolic dimen-
sions are restored to values indistinguishable from control embryos
(Figure 3, Movie S3).
SRF Regulate STARS Transcription via an Autoregulatory
Feed-forward Loop
Ectopic over-expression of STARS significantly increased the
activity of the STARS proximal reporter, which contains
a conserved SRF binding site (position 2305 bp). In vivo binding
of SRF to this site was confirmed by ChIP (Figure 4). This and
similar SRF-chromatin preparations have been used to detect SRF
binding to the sodium-calcium exchanger (NCX1) gene [12]. The
SRF inhibitor CCG-1423, which works by inhibiting MRTF
nuclear localization [9], completely blocked STARS proximal
reporter activity in H9c2 cells. Of interest, over-expression of rat
Figure 1. Whole mount in situ expression of zSTARS in zebrafish embryos. A. Frontal view of 48 hpf embryo showing zSTARS expression in
ventricle (v) and atrium (a). B. Schematic depicting position of ventricular (v) and atrium (a) in the view from part A. C. Expression in somites at 16
somite stage (17 hpf). D. and E. Expression in somites and central nervous system at 24 hpf (D) and 48 hpf (E).
doi:10.1371/journal.pone.0040966.g001
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SRF target genes in H9c2 cells [6], [13].
Discussion
In this study, we isolated the mammalian homologue of STARS
in zebrafish and examined its role in cardiac function and
development. Morpholino knockdown of STARS in the zebrafish
results in abnormal cardiac looping, an enlarged atrium, and
severe contractile dysfunction with resulting marked impaired
circulation.These phenotypes confirm an important role for
STARS in cardiac development and function. Notably, the
cardiac phenotype of zSTARS knockdown resembles that of
a zebrafish morpholino against cardiac troponin T (tnnt2), which
can be mutated in human hypertrophic cardiomyopathy [14].
Both zSTARS and zTnnt2 knockdown result in enlarged atria,
decreased ventricular fractional shortening, and decreased end
diastolic dimension. Thus, genes such as STARS and Tnnt2 which
regulate hypertrophic response in adults may also play critical
roles in cardiac embryonic development. Furthermore, these
examples illustrate how studying developmental phenotypes
arising from zebrafish knockdown can shed light on physiological
mechanisms of cardiac stress response (such as cardiomyopathy
and contractility dysfunction).
Previous studies have demonstrated that STARS can activate srf
transcription activity in vitro [2], [3]. In the present study, we
provide the first in vivo evidence that srf is an essential downstream
target of STARS by showing that injection of zsrf mRNA rescues
cardiac abnormalities caused by morpholino-mediated zSTARS
knockdown. SRF is known to be involved in cardiac development,
structure and function [15], [16] and knockdown of STARS was
shown to reduce SRF activity [5]. In addition, it was demonstrated
that cardiac-specific deletion of SRF in the embryonic heart results
in cardiac defects [15] and deletion of SRF from the adult heart
caused reduced contractility leading to dilated cardiomyopathy
[17]. It is conceivable that knockdown of STARS decreased SRF
activity, which resulted in decreased cardiac function. Consistent
with this hypothesis, SRF expression restored SRF activity and
rescued the cardiac abnormalities as shown here.
In addition to its effects on cardiac function, zSTARS
knockdown causes phenotypes consistent with its non-cardiac sites
of expression, including abnormal somite formation and curvature
and shortening of the longitudinal axis. As the axial skeleton and
skeletal muscle are derived from somites [18], this novel finding
implies an important role for STARS in skeletal muscle de-
velopment. STARS levels were up-regulated in human skeletal
hypertrophy and down-regulated in skeletal muscle atrophy [4]
and in aged skeletal muscle of mice [19] demonstrating a role for
STARS in the maintenance of skeletal muscle. Interestingly, the
same finding was observed for SRF [4], [19] and deletion of SRF
in mice resulted in impaired muscle growth [20]. Collectively,
these results extend the findings in cardiac tissue and suggest that
Figure 2. Developmental phenotype of morpholino-induced knockdown of zSTARS: lateral views of 56 hpf embryos. A. Embryo
injected with control morpholino (with 5 mismatches). The cardiac silhouette is demarcated by arrowheads. The heart tube is looped so that the
ventricle (v) and atrium (a) are closely apposed (inset). Circulating red blood cells (rbc) are visible in a thin rim along the inferior aspect of the yolk and
within the heart. B. Embryo injected with zSTARS morpholino. The heart tube is unlooped so that the ventricle (v) and atrium (a) are co-linear, with
atrial dilation (inset). There is significant edema in the pericardium and over the yolk, with stasis of red blood cells (rbc) over the yolk. C. Lateral view
of entire 56 hpf embryo following injection of control, mismatch morpholino. D. and E. 56 hpf embryos showing representative phenotypes of
zSTARS morpholino injection.
doi:10.1371/journal.pone.0040966.g002
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skeletal muscle development and function.
The present study demonstrates for the first time that STARS-
deficient animals display severe abnormalities in cardiac de-
velopment and function, which were rescued by SRF over-
expression. Our study further highlights the importance of
sarcomeric proteins in cardiac development and biology [21],
[22]. Both STARS and SRF play comparable roles in not just
establishing and maintaining cardiac physiology but also in skeletal
muscle and brain development and function. These findings
provide support for a widespread role of the STARS-SRF
signaling axis in multiple tissues in vivo. Understanding the precise
mechanism of STARS expression and regulation could provide
a novel avenue to dissect the initiation process of cardiac
dysfunction and heart failure.
Materials and Methods
Zebrafish Experiments
All zebrafish experiments were approved by the Subcommittee
on Research Animal Care at Massachusetts General Hospital. The
investigation conformed to the Guide for the Care and Use of Laboratory
Animals published by the US National Institutes of Health (NIH
Publication No. 85-23, revised 1996). IACUC approval number
A3596-01. Zebrafish (AB strain) were raised and maintained using
standard protocols.
An antisense morpholino oligonucleotide was designed against
the translation initiation site, with the sequence: GCTGTACT-
CATGGTGTTTTAATTTG (Gene-Tools, Philomath, OR). An-
tisense and scrambled morpholinos were injected according to
standard procedures [23]. For expression of zebrafish (z) SRF, the
T7 phage promoter sequence was added to the 59 end of the zsrf
cDNA (Open Biosystems, Huntsville, AL) by PCR; zsrf mRNA
was synthesized by in vitro transcription and injected using
published methods [11], [23], [24].
Cloning of Zebrafish STARS Orthologue (zSTARS)
Comparison of the rat STARS sequence with zebrafish
sequences identified a homologous EST (AI721847). Primers were
designed within this sequence for nested 59 and 39 RACE PCR
reactions (SMART RACE, Clontech) on cDNA isolated from
72 hpf (hours post fertilization) zebrafish embryos (Trizol (Invitro-
gen), according to manufacturer’s instructions). 39 RACE PCR
primer sequences were as follows: 59-CGCCGAAGTGTAAC-
Figure 3. Ventricular function and dimensions based on quantitative analysis of high-speed video microscopy. A. Ventricular
dimensions at end-diastole (black bars) and end-systole (white bars). Conditions are identical to those in part a. Values plotted are mean (n=4
embryos) 6 standard deviation. Asterisk (*) denotes statistically significant difference by ANOVA. B. Ventricular fractional shortening observed after
injection of: control mismatched morpholino (MM MO), zSTARS morpholino + srf mRNA (MO + SRF), srf mRNA only (SRF only), or zSTARS morpholino
only (MO only). Values plotted are mean (n=4 embryos) 6 standard deviation. Asterisk (*) denotes statistically significant difference by ANOVA.
doi:10.1371/journal.pone.0040966.g003
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GAAGACACC-39.5 9 RACE PCR primer sequences were as
follows: 59-GAGCTTCTGGCCCTCCATGTGATCT-39 and 59-
ATCGCTGTTGTCGCTCAGAGATGCT-39. Full length cod-
ing sequence of zSTARS was cloned into pCRIITopo using the
TopoTA cloning system (Invitrogen).
In situ Hybridization
Digoxigenin labeled RNA probes were generated by in vitro
transcription according to manufacturer’s instructions (MEGA-
script SP6, Ambion). Embryos were fixed at the indicated times in
4% formaldehyde in PBS overnight at 4uC, and transferred to
methanol for storage at 220uC. In situ hybridization on whole
mount embryos was performed as previously described [11].
Antisense Morpholino Injection
An antisense morpholino oligonucleotide was designed against
the translation initiation site, with the sequence: GCTGTACT-
CATGGTGTTTTAATTTG (Gene-Tools). A control morpho-
lino with 5 mismatches was also designed: GCTcTACT-
gATGcTGTTTaAATaTG. Morpholinos were dissolved in
Danieau’s buffer according to manufacturer’s instructions at
Figure 4. Binding of SRF to the STARS promoter. A. STARS expression activates reporter gene constructs containing the conserved serum
response element (SRE). Luciferase activity is shown for two constructs upstream of the STARS transcription start site. B. Chromatin
immunoprecipitation assays were performed with formaldehyde cross-linked chromatin isolated from feline adult cardiomyocytes. Asterisk (*)
denotes PCR primer locations. Immunoprecipitations were performed without primary antibody (No Ab) as a negative control, with anti-SRF
antibody. Input DNA is also shown as a positive control. Similar results were observed in four independent experiments. C. The SRF inhibitor CCG-
1423 (1 mM) abolished STARS 2365/+60 promoter-reporter activity in H9c2 cells (n=3 experiments, in triplicates).
doi:10.1371/journal.pone.0040966.g004
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stage [23].
RNA Injection
The T7 phage promoter sequence was added to the 59 end of
the cDNA encoding zsrf (Open Biosystems, Huntsville, AL) by
PCR. This template was used to synthesize capped mRNA
encoding the full-length coding sequence of srf by in vitro
transcription (mMessage Machine, Ambion). mRNA was diluted
in Danieau’s buffer to a final concentration of 100 ng/mL and co-
injected with morpholino (at 400 mM) as above. n=4 for each
condition.
Ventricular Function Measurements and M-mode
Recordings
Extensive description on the measurement of cardiovascular
function and the creation of m-mode images have been published
elsewhere. Ventricular size and fractional shortening were
measured as previously described [24].
STARS Promoter-reporter Transfection Assays and mRNA
Analysis
The rat STARS21585/+60-Luc reporter was generated as
described elsewhere [7]. For the 2365/+60 region, the rat STARS
5-upstream region was PCR-amplified using primers -365-MluI-
Forward: 59-GTACGCGTTACAGAGGTTTAAGTGAGAGC -
39 and +60-BglII-Reverse: 59- CCAGATCTCAGGC-
TACCTGTTTCTTCTC-39, gel-purified and cloned into
pGEMTEasy vector (Promega). This plasmid was subsequently
restriction digested by MluI and BglII and the insert was gel-
purified and subcloned directionally into the pGL3-Promoter Luc
vector (Promega). The STARS-365/+60 Luc reporter was
sequenced for authenticity.
Transfection of STARS Luciferase reporters were done as
described [7]. Briefly, 0.5 ug of STARS reporter plasmids (or its
empty control vector pGL3-promoter) and 10 ng of Renilla
reporter was cotransfected into H9c2 cells (60% confluency) in 24-
well plates using the JetPei reagent (Source BioScience). For
standard transfection, cell extracts were measured for activity after
48 h using a Dual-Luciferase Assay kit (Promega). For SRF
inhibition experiments, CCG-1423 (1 mM; Sigma) was added 24 h
post-transfection and left for a further 24 h before assayed.
Chromatin Immunoprecipitation (ChIP)
The feline cardiomyocyte chromatin was a gift from Dr DL
Menick [12], [25] obtained using the Santa Cruz SRF G-20
antibody (sc-335). The feline STARS proximal promoter was PCR
amplified from the immunoprecipitated and non-immunoprecipi-
tated chromatin (negative control) using the following primers:
STARS-PP-Fw Sense: 59-CGGAGCTCAGAACACCGTCA-
GAGCCATAGC-39, and STARS-PP-Rv Antisense- 59-
CCAAGCTTCAGGCTACCTGTTTCTTCTC-39. The input
DNA was used as the positive control.
Statistical Analysis
Data are presented as mean6SEM. Data were analyzed by
ANOVA followed by Bonferroni post hoc testing (Graph Pad
Prism, La Jolla, CA).
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